G. Morris

In vivo sensitization of human lung carcinoma to bleomycin by the cysteine proteinase inhibitor E-64.

J. Lazo, S. Sebti, J. Mistry, 1992, Oncology research.

In vivo circumvention of human colon carcinoma resistance to bleomycin.

J. Lazo, S. Sebti, J. Mistry, 1992, Cancer research.

Dosimetric evaluation of copper-64 in copper-67-2IT-BAT-Lym-1 for radioimmunotherapy.

G. Denardo, S. Denardo, S. Shen, 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Decreased C-MYC and BCL2 expression correlates with methylprednisolone-mediated inhibition of Raji lymphoma growth.

G. Denardo, S. Denardo, P. Gumerlock, 1997, Biochemical and molecular medicine.

Cysteine proteinase inhibitors and bleomycin-sensitive and -resistant cells.

J. Lazo, S. Sebti, J. Mistry, 1991, Biochemical pharmacology.

Synthesis and Evaluation of Fluoromycin: A Novel Fluorescence-labeled Derivative of Talisomycin Siot,1

J. Lazo, S. Sebti, R. Mujumdar, 2006 .

Conjugates of COL-1 monoclonal antibody and β-D-galactosidase can specifically kill tumor cells by generation of 5-fluorouridine from the prodrug β-D-galactosyl-5-fluorouridine

J. Kenten, R. Titmas, M. Darsley, 2007, Cell Biophysics.